Atom Investors LP Mirati Therapeutics, Inc. Transaction History

Atom Investors LP

  • $906 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$41.99 - $62.38 $102,413 - $152,144
-2,439 Reduced 9.83%
22,362 $1.31 Million
Q3 2023

Nov 14, 2023
BUY
$27.8 - $45.35 $689,467 - $1.12 Million
24,801 New
24,801 $1.08 Million
Q2 2021

Aug 16, 2021
SELL
$144.0 - $179.73 $1.14 Million - $1.42 Million
-7,896 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$158.92 - $221.61 $553,041 - $771,202
-3,480 Reduced 30.59%
7,896 $1.35 Million
Q4 2020

Feb 16, 2021
BUY
$162.05 - $240.27 $1.84 Million - $2.73 Million
11,376 New
11,376 $2.5 Million

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email